 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Centenary Institute |
| Street 1: | Building 93, Royal Prince Alfred Hospital |
| Street 2: | Misseden Road |
| City: | Camperdown |
| Province: | New South Wales |
| Post Code: | 2050 |
| Country: | Australia |
| Phone: | +61 2 9565 6100 |
| Organization Email: | b.saunders@centenary.org.au |
| Web Site: | http://www.tb.org.au/ also www.centenary.org.au |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Technical agencies |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Academic / Research Institution |
| Organization Type - Secondary: | None |
| Organization Description: | |
| The Centenary Institute conducts basic medical research into cancer, cardiovascular disease and infectious diseases. The Centenary Institute houses the largest tuberculosis (TB) research group in Australia and we are the only facility in the country permitted to work with experimental tuberculosis infection. We have a team of 23 dedicated researchers, headed up by Professor Warwick Britton. Our researchers work on various TB projects to improve the knowledge of MTB and ultimately develop methods, tests, vaccines and drugs to control TB. We have developed a partnership with the National Lung Hospital in Hanoi, Vietnam. We are currently carrying out two key research projects with the NLH including analysing blood samples to identify genetic susceptibility and a public control study to screen people in households where someone has TB. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 11 - 25 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 6 - 10 |
| How did you hear about the Stop TB Partnership: | World TB Day |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| The Centenary Institution is lead institute for a recently awarded centre of Research Excellence for Tuberculosis Control in Australia. A number of the investigators on this are members of State and National Committees responsible for recommending and implementing National TB Control Plan. | |
Geographical Reach | |
| Which country is your headquarters located in: | Australia |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Australia Viet Nam |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Collaborative project on enhanced case detection in Vietam Drug-Resistant TB: Monitoring drug resistance in Australia with new molecular tools Laboratory Strengthening: Transfer of new technologies to laboratories in Vietnam New TB Drugs: Basic research on structure based drug design for TB New TB Vaccines: Extensive program in development and testing of new T vaccines Fundamental Research: Basic studies on immunological control of TB in humans and animal models and immunogenetics. Research: Operational studies in Vietnam |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | March 14, 2011 |
| Last updated: | June 17, 2014 |